The pharmaceutical company isolated its data centers and temporarily closed some production facilities after being made aware of the attack. The company’s centers in the United Kingdom, Brazil, India, Russia and the U.S. were all affected.
The company didn’t reveal details about the attack, but Mukesh Rathi, the company’s CIO, said, “We do not foresee any major impact on our operations due to this incident.”
Dr. Reddy’s is a pharmaceutical company focused on gastroenterology, oncology, pain management and cardiology. It is also conducting a phase 2/3 trial of the Sputnik V COVID-19 vaccine.
More articles on surgery centers:
5 employees of U of New Mexico outpatient surgery center test positive for COVID-19
ASC leaders on top priorities during COVID-19 pandemic
ASCs projected to take 68% of orthopedic surgeries by mid-decade — 5 insights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
